Literature DB >> 32941

A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia.

B M Camitta, E D Thomas, D G Nathan, R P Gale, K J Kopecky, J M Rappeport, G Santos, E C Gordon-Smith, R Storb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 32941

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  57 in total

1.  Predicting response to immunosuppressive therapy in childhood aplastic anemia.

Authors:  Nao Yoshida; Hiroshi Yagasaki; Asahito Hama; Yoshiyuki Takahashi; Yoshiyuki Kosaka; Ryoji Kobayashi; Hiromasa Yabe; Takashi Kaneko; Masahiro Tsuchida; Akira Ohara; Tatsutoshi Nakahata; Seiji Kojima
Journal:  Haematologica       Date:  2011-01-27       Impact factor: 9.941

Review 2.  Paediatric bone marrow transplantation using donors other than HLA genotypically identical siblings.

Authors:  J M Hows
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

3.  Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia.

Authors:  Atsushi Narita; Hideki Muramatsu; Yuko Sekiya; Yusuke Okuno; Hirotoshi Sakaguchi; Nobuhiro Nishio; Nao Yoshida; Xinan Wang; Yinyan Xu; Nozomu Kawashima; Sayoko Doisaki; Asahito Hama; Yoshiyuki Takahashi; Kazuko Kudo; Hiroshi Moritake; Masao Kobayashi; Ryoji Kobayashi; Etsuro Ito; Hiromasa Yabe; Shouichi Ohga; Akira Ohara; Seiji Kojima
Journal:  Haematologica       Date:  2015-08-27       Impact factor: 9.941

4.  Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia.

Authors:  Roland Chu; Ruta Brazauskas; Fangyu Kan; Asad Bashey; Christopher Bredeson; Bruce Camitta; Kuang-Yueh Chiang; Haydar Frangoul; Robert Peter Gale; Adrian Gee; Biju George; Frederick D Goldman; Thomas G Gross; Vikas Gupta; Gregory A Hale; Luis Isola; Alvaro Urbano Ispizua; Hillard Lazarus; Judith Marsh; James Russell; Mitchell Sabloff; Edmund K Waller; Mary Eapen
Journal:  Biol Blood Marrow Transplant       Date:  2010-10-27       Impact factor: 5.742

5.  Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens.

Authors:  Richard E Champlin; Waleska S Perez; Jakob R Passweg; John P Klein; Bruce M Camitta; Eliane Gluckman; Christopher N Bredeson; Mary Eapen; Mary M Horowitz
Journal:  Blood       Date:  2007-02-01       Impact factor: 22.113

6.  Reticulocyte maturity as an indicator for estimating qualitative abnormality of erythropoiesis.

Authors:  K Watanabe; Y Kawai; K Takeuchi; N Shimizu; H Iri; Y Ikeda; B Houwen
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

7.  Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children.

Authors:  Dae Chul Jeong; Nack Gyun Chung; Bin Cho; Yao Zou; Min Ruan; Yoshiyuki Takahashi; Hideki Muramatsu; Akira Ohara; Yoshiyuki Kosaka; Wenyu Yang; Hack Ki Kim; Xiaofan Zhu; Seiji Kojima
Journal:  Haematologica       Date:  2013-11-08       Impact factor: 9.941

Review 8.  Transfusion-induced bone marrow transplant rejection due to minor histocompatibility antigens.

Authors:  Seema R Patel; James C Zimring
Journal:  Transfus Med Rev       Date:  2013-10-03

9.  Danazol Treatment for Telomere Diseases.

Authors:  Danielle M Townsley; Bogdan Dumitriu; Delong Liu; Angélique Biancotto; Barbara Weinstein; Christina Chen; Nathan Hardy; Andrew D Mihalek; Shilpa Lingala; Yun Ju Kim; Jianhua Yao; Elizabeth Jones; Bernadette R Gochuico; Theo Heller; Colin O Wu; Rodrigo T Calado; Phillip Scheinberg; Neal S Young
Journal:  N Engl J Med       Date:  2016-05-19       Impact factor: 91.245

10.  Transformation of severe aplastic anemia into acute myeloblastic leukemia with monosomy 7.

Authors:  S Hashino; M Imamura; J Tanaka; S Kobayashi; M Musashi; M Kasai; M Asaka
Journal:  Ann Hematol       Date:  1996-05       Impact factor: 3.673
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.